Key result
LAAC safety reassessment in immunosuppressed patients provides no specific clinical results.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
LAA closure safety in immunosuppressed patients remains inconclusive; leaves open need for dedicated prospective studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Çelik et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: